Sfoglia per AUTORE
PETERS S
Collezione AOU Novara
Items : 2
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1?50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. in Journal for immunotherapy of cancer / J Immunother Cancer. 2025 Feb 4;13(2):e010674. doi: 10.1136/jitc-2024-010674.
2025
AOU San Luigi di Orbassano
AOU Novara
AOU San Luigi di Orbassano
AOU Novara
Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...
Pleural mesothelioma risk by industry and occupation: results from the Multicentre Italian Study on the Etiology of Mesothelioma (MISEM). in Environmental health : a global access science source / Environ Health. 2022 Jun 18;21(1):60. doi: 10.1186/s12940-022-00869-5.
2022
AOU Novara
AOU Novara
Migliore E; Consonni D; Peters S; Vermeulen RCH; Kromhout H; Baldassarre A; Cavone D; Chellini E; Magnani C; Mensi C; Merler E; Musti M; Marinaccio A; Mirabelli D;